| 000 | 01414 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512020508.0 | ||
| 264 | 0 | _c19890915 | |
| 008 | 198909s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPirker, R | |
| 245 | 0 | 0 |
_aEnhancement of the activity of immunotoxins by analogues of verapamil. _h[electronic resource] |
| 260 |
_bCancer research _cSep 1989 |
||
| 300 |
_a4791-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aADP Ribose Transferases |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBacterial Toxins |
| 650 | 0 | 4 | _aCalcium Channel Blockers |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aExotoxins _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotoxins _xpharmacology |
| 650 | 0 | 4 | _aLethal Dose 50 |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aProtein Synthesis Inhibitors |
| 650 | 0 | 4 |
_aRicin _xpharmacology |
| 650 | 0 | 4 |
_aTumor Cells, Cultured _xdrug effects |
| 650 | 0 | 4 | _aTumor Stem Cell Assay |
| 650 | 0 | 4 |
_aVerapamil _xanalogs & derivatives |
| 650 | 0 | 4 | _aVirulence Factors |
| 650 | 0 | 4 | _aPseudomonas aeruginosa Exotoxin A |
| 700 | 1 | _aFitzGerald, D J | |
| 700 | 1 | _aRaschack, M | |
| 700 | 1 | _aFrank, Z | |
| 700 | 1 | _aWillingham, M C | |
| 700 | 1 | _aPastan, I | |
| 773 | 0 |
_tCancer research _gvol. 49 _gno. 17 _gp. 4791-5 |
|
| 999 |
_c2793895 _d2793895 |
||